New Oligonucleotide Characterization Workflows With LC-MS/MS

Mass spectrometry has been growing as the analytical technique of choice to analyze and quantitate oligonucleotide drugs from discovery to QC. Characterization of production related impurities or degradation products is of key importance during the approval process of such biopharmaceutical products. LC-MS/MS provides essentials insights in the identity, amount and sequence of the drug and its impurities.

In this webinar you will:

Gain a deeper understanding of how to measure oligonucleotide in a robust environment with high isotopic fidelity mass spectrometry
Discover how OligoQuest™ simplifies the characterization and quantification of oligonucleotide and oligonucleotide degradation products
Learn about tools to simplify the annotation of oligonucleotide MS² data

For Research Use Only. Not for use in clinical diagnostic procedures.

Following our interaction with you, Bruker Daltonics and its affiliates within the Bruker group (“Bruker”) would like to be able to stay in contact with you and inform you about the latest technological achievements and upcoming events as well as the products and services offered by Bruker. If you are interested in hearing from us in the future, we will need your consent in accordance with applicable data protection laws to be allowed to engage in marketing activities using your contact information.

To view the promises that we make to you regarding your personal information, please view Bruker`s privacy policy. For questions related to privacy, please send your inquiry to privacy@bruker.com

If you prefer not to receive promotional e-mails from Bruker in the future, you can unsubscribe at any time here.